FDA Clearance Tracker · K250495
MINI VP1 (PL67_F); MINI VP1 (PL61_F)
Last checked: Nov 19, 2026Latest source record: Aug 1, 2025 (this decision)Source: openFDAMethods & limitations
Decided
Aug 1, 2025
Substantially Equivalent
Time to decision
162 days
Received Feb 20, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K250495
- Device name
- MINI VP1 (PL67_F); MINI VP1 (PL61_F)
- Applicant
- Avizor S.A.
- Applicant location
- LeganéS, ES
- Received
- Feb 20, 2025
- Decided
- Aug 1, 2025
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Case, Contact Lens (LRX)
- Device class
- Class II
- Regulation
- 21 CFR 886.5928
- Specialty
- Ophthalmology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code LRX. The earliest in FDA's data is K840691, decided May 18, 1984.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K250495
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Avizor S.A.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.